129 related articles for article (PubMed ID: 26253792)
1. Common single nucleotide polymorphisms at the NPC1L1 gene locus significantly predict cardiovascular risk in coronary patients.
Muendlein A; Leiherer A; Saely CH; Rein P; Zanolin D; Kinz E; Brandtner EM; Fraunberger P; Drexel H
Atherosclerosis; 2015 Sep; 242(1):340-5. PubMed ID: 26253792
[TBL] [Abstract][Full Text] [Related]
2. Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary disease.
Li Y; Li J; Tang X; Xu J; Liu R; Jiang L; Tian J; Zhang Y; Wang D; Sun K; Xu B; Zhao W; Hui R; Gao R; Song L; Yuan J; Zhao X
BMC Med Genomics; 2024 Jan; 17(1):22. PubMed ID: 38233830
[TBL] [Abstract][Full Text] [Related]
3. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study.
Ference BA; Majeed F; Penumetcha R; Flack JM; Brook RD
J Am Coll Cardiol; 2015 Apr; 65(15):1552-61. PubMed ID: 25770315
[TBL] [Abstract][Full Text] [Related]
4. Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment.
Simon JS; Karnoub MC; Devlin DJ; Arreaza MG; Qiu P; Monks SA; Severino ME; Deutsch P; Palmisano J; Sachs AB; Bayne ML; Plump AS; Schadt EE
Genomics; 2005 Dec; 86(6):648-56. PubMed ID: 16297596
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.
Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA
Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339
[TBL] [Abstract][Full Text] [Related]
6. The g.-762T>C polymorphism of the NPC1L1 gene is common in Chinese and contributes to a higher promoter activity and higher serum cholesterol levels.
Chen CW; Hwang JJ; Tsai CT; Su YN; Hsueh CH; Shen MJ; Lai LP
J Hum Genet; 2009 Apr; 54(4):242-7. PubMed ID: 19265861
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly.
Polisecki E; Peter I; Simon JS; Hegele RA; Robertson M; Ford I; Shepherd J; Packard C; Jukema JW; de Craen AJ; Westendorp RG; Buckley BM; Schaefer EJ;
J Lipid Res; 2010 May; 51(5):1201-7. PubMed ID: 19752398
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Niemann-Pick C1-like 1 (NPC1L1) genetic polymorphisms and haplotypes in Chinese Han population.
Lou XY; Qin CZ; Bao MH; Hu DL; Chen F; Sun H; Chen Y; Guo D; Zhang W; Cheng Y; Zhou HH
Pharmazie; 2015 Sep; 70(9):581-5. PubMed ID: 26492642
[TBL] [Abstract][Full Text] [Related]
9. Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population.
Tsai AK; Li N; Hanson NQ; Tsai MY; Tang W
Atherosclerosis; 2009 Dec; 207(2):487-91. PubMed ID: 19596330
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphism and frequencies of the NPC1L1 gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia.
Kashiwabara Y; Kobayashi Y; Koba S; Kohyama N; Ohbayashi M; Murayama JI; Hirano T; Kobayashi Y; Yamamoto T
J Clin Pharm Ther; 2014 Oct; 39(5):551-4. PubMed ID: 24861377
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Expression of Niemann-Pick C1-Like 1, a Cholesterol Reabsorber from Bile, Exacerbates Western Diet-Induced Atherosclerosis in LDL Receptor Mutant Mice.
Yamamoto H; Yamanashi Y; Takada T; Mu S; Tanaka Y; Komine T; Suzuki H
Mol Pharmacol; 2019 Jul; 96(1):47-55. PubMed ID: 31064810
[TBL] [Abstract][Full Text] [Related]
12. Inactivating mutations in NPC1L1 and protection from coronary heart disease.
; Stitziel NO; Won HH; Morrison AC; Peloso GM; Do R; Lange LA; Fontanillas P; Gupta N; Duga S; Goel A; Farrall M; Saleheen D; Ferrario P; König I; Asselta R; Merlini PA; Marziliano N; Notarangelo MF; Schick U; Auer P; Assimes TL; Reilly M; Wilensky R; Rader DJ; Hovingh GK; Meitinger T; Kessler T; Kastrati A; Laugwitz KL; Siscovick D; Rotter JI; Hazen SL; Tracy R; Cresci S; Spertus J; Jackson R; Schwartz SM; Natarajan P; Crosby J; Muzny D; Ballantyne C; Rich SS; O'Donnell CJ; Abecasis G; Sunaev S; Nickerson DA; Buring JE; Ridker PM; Chasman DI; Austin E; Kullo IJ; Weeke PE; Shaffer CM; Bastarache LA; Denny JC; Roden DM; Palmer C; Deloukas P; Lin DY; Tang ZZ; Erdmann J; Schunkert H; Danesh J; Marrugat J; Elosua R; Ardissino D; McPherson R; Watkins H; Reiner AP; Wilson JG; Altshuler D; Gibbs RA; Lander ES; Boerwinkle E; Gabriel S; Kathiresan S
N Engl J Med; 2014 Nov; 371(22):2072-82. PubMed ID: 25390462
[TBL] [Abstract][Full Text] [Related]
13. Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol.
Kim DS; Burt AA; Ranchalis JE; Jarvik ER; Rosenthal EA; Hatsukami TS; Furlong CE; Jarvik GP
J Lipid Res; 2013 May; 54(5):1512-20. PubMed ID: 23482652
[TBL] [Abstract][Full Text] [Related]
14. Novel polymorphism of the HMGCR gene related to the risk of diabetes in premature triple-vessel disease patients.
Zhao X; Tang X; Xu J; Liu R; Huang K; Li J; Li Y; Jiang L; Xu L; Zhang Y; Wang D; Hui R; Gao R; Song L; Yuan J
J Gene Med; 2022 Sep; 24(9):e3445. PubMed ID: 35998373
[TBL] [Abstract][Full Text] [Related]
15. Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases.
Pirillo A; Catapano AL; Norata GD
Curr Med Chem; 2016; 23(10):983-99. PubMed ID: 26923679
[TBL] [Abstract][Full Text] [Related]
16. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
Davis HR; Altmann SW
Biochim Biophys Acta; 2009 Jul; 1791(7):679-83. PubMed ID: 19272334
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients.
Muendlein A; Saely CH; Leiherer A; Fraunberger P; Kinz E; Rein P; Vonbank A; Zanolin D; Malin C; Drexel H
Atherosclerosis; 2014 Dec; 237(2):632-8. PubMed ID: 25463098
[TBL] [Abstract][Full Text] [Related]
18. Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis.
Muendlein A; Geller-Rhomberg S; Saely CH; Winder T; Sonderegger G; Rein P; Beer S; Vonbank A; Drexel H
Atherosclerosis; 2009 Oct; 206(2):494-9. PubMed ID: 19380133
[TBL] [Abstract][Full Text] [Related]
19. In-vitro characterization of the six clustered variants of NPC1L1 observed in cholesterol low absorbers.
Yamanashi Y; Takada T; Suzuki H
Pharmacogenet Genomics; 2009 Nov; 19(11):884-92. PubMed ID: 19823104
[TBL] [Abstract][Full Text] [Related]
20. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.
Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L
Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
